Medigene AG

Corporate Details

ISIN(s):

DE000A40ESG2

LEI:

391200I33JD2DKZGDX06

Country:

Germany

Address:

Lochhamer Straße 11, 82152 Planegg

Website:

https://medigene.com/

Sector:

Health Care

Industry:

Biotechnology

Description

Medigene AG (FWB: MDG1) is a publicly listed, immuno-oncology platform company dedicated to developing t cell receptor (tcr)-guided therapies to effectively eliminate cancer Generation of optimal affinity 3S (specificity, sensitivity, and safety ) TCRs is the foundation for our integrated proprietary End-to-End Platform which includes multiple TCR generation and optimization technologies as well as product enhancement technologies. These 3S- TCRs show great potential for application across various modalities, including TCR-T cell engagers, as well as TCR-natural killer cell therapies and TCR-T therapies.